50+ years of proof: Chelation could save
hundreds of thousands of lives...every year

From its earliest clinical tests, chelation therapy has consistently demonstrated a remarkable ability to cleanse the system of metals and other deposits that lead to so-called age-related disease. In 1955, research conducted at the Providence Hospital in Detroit, Michigan, found that EDTA dissolves metastatic calcium. i.e., calcium that has been deposited where it is not wanted. Namely, arteries, joints, kidneys, and even the bones of the inner ear. In other words, chelation therapy appeared to be a powerful antidote to and preventive against atherosclerosis, arthritis, kidney stones, and otosclerosis (hearing loss relat-ed to the calcification of the bones in the ear).11

Nineteen out of 20 heart patients enjoyed measurable improvement in energy and activity level

The first systematic study of EDTA in people with atherosclerosis was published in 1956. Twenty patients with confirmed heart disease were given a series of 30 EDTA treatments intravenously. Nineteen of the patients experienced improvement, as measured by an increase in physi-cal activity.12

Chest pain reduced...energy and work capacity increased

In another study conducted four years later, a similar group found that three months of ETDA infusions caused decreases in the severity and frequency of anginal episodes, reduced use of nitroglycerin (a common antiangina drug), increased work capacity and improved ECG (electrocardiogram) results.13

Thousands upon thousands of patients have already experienced the powerful benefits of chelation treatment

Since these early studies, hundreds of papers have been published on the favorable effects of chelation therapy in a variety of chronic diseases. There have even been two massive meta-analyses of published and unpublished studies

Continued on page 6